Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Gross Profit (2016 - 2025)

Historic Gross Profit for Phibro Animal Health (PAHC) over the last 14 years, with Q4 2025 value amounting to $132.7 million.

  • Phibro Animal Health's Gross Profit rose 3022.09% to $132.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $467.0 million, marking a year-over-year increase of 3263.17%. This contributed to the annual value of $399.9 million for FY2025, which is 2773.95% up from last year.
  • As of Q4 2025, Phibro Animal Health's Gross Profit stood at $132.7 million, which was up 3022.09% from $119.8 million recorded in Q3 2025.
  • Phibro Animal Health's 5-year Gross Profit high stood at $132.7 million for Q4 2025, and its period low was $64.7 million during Q3 2021.
  • For the 5-year period, Phibro Animal Health's Gross Profit averaged around $84.4 million, with its median value being $77.9 million (2022).
  • Its Gross Profit has fluctuated over the past 5 years, first plummeted by 224.17% in 2023, then surged by 4346.13% in 2025.
  • Phibro Animal Health's Gross Profit (Quarter) stood at $70.7 million in 2021, then grew by 9.5% to $77.4 million in 2022, then rose by 1.59% to $78.6 million in 2023, then rose by 29.58% to $101.9 million in 2024, then soared by 30.22% to $132.7 million in 2025.
  • Its last three reported values are $132.7 million in Q4 2025, $119.8 million for Q3 2025, and $110.0 million during Q2 2025.